摘要
Objective:To explore the clinical outcomes of the infertile women with retrieved oocytes less than or equal to 5 undergoing in vitro fertilization-embryo transfer(IVF-ET) or intracytoplasmic sperm injection(1CSI). Methods:The clinical data of 216 embryo transfer cycles with retrieved oocytes less than or equal to 5 during the procedure of IVF/ICSI in Reproductive Medicine Center of the 105th Hospital of PLA from Jul.2008 to Dec.2011 were analyze retrospectively.All the patients were divided into group A(< 35 years),group B(35-39 years) and group C(≥40 years) according to the ages,and 409 IVF/ICSI cycles with patients’ age less than 35 years old and 6-15 retrieved oocytes in the same period were served as controlled group.Then the patients≥35 years were subdivided into gonadotropin-releasing hormone agonist(GnRH-a) long protocol group,GnRH-a short group and GnRH antagonist group according to the protocols of controlled ovarian hyperstimulation(COH).The clinical date and the outcomes were analyzed and compared among all groups. Results:There were significantly differences in clinical pregnancy rate(38.3%vs.19.4%) and early abortion rate(16.1%vs.50.0%) between group A and group C(P<0.05),and there were no significant differences in clinical pregnancy rate(38.3%vs.41.6%)and early abortion rate(16.1%vs.10.0%) between group A and control group(P>0.05).There were no significant differences in clinical pregnancy rates(29.01%vs.26.1%vs.25.9%) and early abortion rates(33.3%vs.33.3%vs.40.0%) among GnRH-a long protocol group,GnRH-a short group and GnRH antagonist group(P>0.05). Conclusions:Relatively satisfactory clinical outcomes of IVF/ICSI would still be got for the patients <35 years with retrieved oocytes less than or equal to 5,but whatever COH protocols such as GnRH-a long protocol,GnRH-a short and GnRH antagonist could not improve the outcomes of IVF/ICSI for the patients aged≥35 with retrieved oocytes less than or equal to 5.
Objective: To explore the clinical outcomes of the infertile women with retrieved oocytes less than or equal to 5 undergoing in vitro fertilization-embryo transfer (IVF-ET) or intracytoplasmic sperm injection (ICSI). Methods: The clinical data of 216 embryo transfer cycles with retrieved oocytes less than or equal to 5 during the procedure of IVF/ICSI in Reproductive Medicine Center of the 105th Hospital of PLA from Jul. 2008 to Dec. 2011 were analyze retrospectively. All the patients were divided into group A (〈 35 years), group B (35-39 years) and group C (≥40 years) according to the ages, and 409 IVF/ICSI cycles with patients" age less than 35 years old and 6-15 retrieved oocytes in the same period were served as controlled group. Then the patients ≥ 35 years were subdivided into gonadotropin-releasing hormone agonist (GnRH-a) long protocol group, GnRH-a short group and GnRH antagonist group according to the protocols of controlled ovarian hyperstimulation (COH). The clinical date and the outcomes were analyzed and compared among all groups. Results: There were significantly differences in clinical pregnancy rate(38.3 % vs. 19.4%) and early abortion rate (16.1% vs. 50.0%) between group A and group C (P〈0.05), and there were no significant differences in clinical pregnancy rate(38.3% vs. 41.6%)and early abortion rate (16.1G vs. 10.0%) between group A and control group (P〉0.05). There were no significant differences in clinical pregnancy rates (29.01% vs. 26.1% vs. 25.9%) and early abortion rates (33.3% vs. 33.3% vs. 40.0%) among GnRH-a long protocol group, GnRH-a short group and GnRH antagonist group (P〉0.05). Conclusions: Relatively satisfactory clinical outcomes of IVF/ICSI would still be got for the patients 〈35 years with retrieved oocytes less than or equal to 5, but whatever COH protocols such as GnRH-a long protocol, GnRH-a short and GnRH antagonist could not improve the outcomes of IVF/ICSI for the patients aged ≥35 with retrieved oocytes less than or equal to 5.
出处
《生殖医学杂志》
CAS
2012年第B12期36-41,共6页
Journal of Reproductive Medicine